article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Morgan, along withBofA Securities, Cowen, Credit Suisse, Nomura and RBC Capital Markets, Baird, Needham & Company, Oppenheimer & Co., Piper Sandler and Valuable Capital.

Pricing 113
article thumbnail

Avidity Biosciences Prices IPO

socalTECH

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company priced above its initial estimated offering range of $14.00 READ MORE>>.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evofem Prices $50M Offering

socalTECH

San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.

Pricing 113
article thumbnail

San Diego's Seismic Snags $100M, Joins Unicorns

socalTECH

San Diego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. Rowe Price, plus General Atlantic, JMI Equity, and Jackson Square Ventures. The funding round came from Lightspeed Venture Partners, T.

San Diego 113
article thumbnail

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00 READ MORE>>.

Pricing 113
article thumbnail

Ignyta Prices IPO

socalTECH

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. The IPO will raised $48.0M for the company.

Pricing 138
article thumbnail

Avidity Biosciences Ups Public Offering Size

socalTECH

San Diego-based biopharmaceuticals company Avidity Biosciences said on Thursday that it has upsized its public offering, and will be offering up 12,000,000 shares of its common stock at a price to the public of $17.25 per share, and is now expecting to raise $207M for the company. The company is working on RNA therapeutics.

San Diego 113